2018
137 Safety of Second Round of Eight Injections of Collagenase Clostridium Histolyticum (CCH) in the Treatment of Peyronie's Disease
Bryson C, Xu I, Honig S. 137 Safety of Second Round of Eight Injections of Collagenase Clostridium Histolyticum (CCH) in the Treatment of Peyronie's Disease. The Journal Of Sexual Medicine 2018, 15: s35-s36. DOI: 10.1016/j.jsxm.2017.11.095.Peer-Reviewed Original ResearchVasectomy
Pan S, Honig S. Vasectomy. 2018, 417-422. DOI: 10.1016/b978-0-12-801238-3.64934-6.Peer-Reviewed Original Research
2016
124 Dissecting the Peyronie’s Disease Questionnaire (PDQ): What Matters Most in the Initial Evaluation of Patients with Peyronie’s Disease ?
Bryson C, Lu A, Rosoff J, Su J, Honig S. 124 Dissecting the Peyronie’s Disease Questionnaire (PDQ): What Matters Most in the Initial Evaluation of Patients with Peyronie’s Disease ? The Journal Of Sexual Medicine 2016, 13: s58-s59. DOI: 10.1016/j.jsxm.2016.02.130.Peer-Reviewed Original Research125 Initial Peyronie’s Disease Questionnaire Bother Scores Do Not Correlate with Degree of Penile Curvature in Patients with Peyronie’s Disease
Su J, Lu A, Bryson C, Rosoff J, Honig S. 125 Initial Peyronie’s Disease Questionnaire Bother Scores Do Not Correlate with Degree of Penile Curvature in Patients with Peyronie’s Disease. The Journal Of Sexual Medicine 2016, 13: s59-s59. DOI: 10.1016/j.jsxm.2016.02.131.Peer-Reviewed Original Research
2013
Intralesional collagenase in the treatment of Peyronie’s disease
Honig SC. Intralesional collagenase in the treatment of Peyronie’s disease. Therapeutic Advances In Urology 2013, 6: 47-53. PMID: 24688600, PMCID: PMC3943365, DOI: 10.1177/1756287213509849.Peer-Reviewed Original ResearchPeyronie's diseaseEvidence of efficacyMinimal side effectsUnited States FoodPharmacologic agentsFirst drugLarge dosesSide effectsDrug AdministrationDiseaseEuropean AssociationStates FoodSexual medicineTreatmentWound remodelingCollagenaseCurrent dataPharmacotherapyGradeVerapamilInterferonLocal effectsAgentsSteroidsAdministration1660 INTEGRATED SAFETY PROFILE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN CLINICAL STUDIES EVALUATING THE TREATMENT OF PEYRONIE'S DISEASE
Carson C, Sadeghi-Nejad H, Smith T, Kaufman G, Gilbert K, Honig S. 1660 INTEGRATED SAFETY PROFILE OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM IN CLINICAL STUDIES EVALUATING THE TREATMENT OF PEYRONIE'S DISEASE. Journal Of Urology 2013, 189: e683. DOI: 10.1016/j.juro.2013.02.3074.Peer-Reviewed Original Research
2008
Local therapy for Peyronie’s disease
Szobota J, Honig S. Local therapy for Peyronie’s disease. Current Sexual Health Reports 2008, 5: 70. DOI: 10.1007/s11930-008-0013-x.Peer-Reviewed Original ResearchPeyronie's diseaseMechanical therapyLocal therapyEfficacious medical treatmentPlacebo-controlled trialFlu-like symptomsMulticenter clinical trialNoncontrolled trialsErectile functionIntralesional treatmentPenile curvatureClinical trialsInvasive modalitiesMedical treatmentTherapyNatural historyEnd pointDiseasePlaque sizeTrialsPositive resultsTreatmentShow promisePast yearMulticenter
2005
935: Single-Blind, Multi-Center, Placebo-Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon Alpha-2b in the Nonsurgical Treatment of Peyronie's Disease
Kendirci M, Matern R, Nowfar S, Venable D, Honig S, McCullough A, Hakim L, Nehra A, Pryor J, Templeton L, Hellstrom W. 935: Single-Blind, Multi-Center, Placebo-Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon Alpha-2b in the Nonsurgical Treatment of Peyronie's Disease. Journal Of Urology 2005, 173: 253. DOI: 10.1016/s0022-5347(18)35091-2.Peer-Reviewed Original Research